Holen Sie sich die Stockscreener-App
1.16
5.69%
-0.07
Handel nachbörslich:
1.17
0.01
+0.86%
Schlusskurs vom Vortag:
$1.23
Offen:
$1.26
24-Stunden-Volumen:
800.29K
Relative Volume:
1.53
Marktkapitalisierung:
$53.02M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-40.56M
KGV:
-0.9915
EPS:
-1.17
Netto-Cashflow:
$-35.28M
1W Leistung:
+4.50%
1M Leistung:
-6.45%
6M Leistung:
-22.67%
1J Leistung:
-61.97%
1-Tages-Spanne:
$1.16
$1.32
1-Wochen-Bereich:
$1.06
$1.32
52-Wochen-Spanne:
$0.8505
$4.29
Pds Biotechnology Corporation Stock (PDSB) Company Profile
Firmenname
Pds Biotechnology Corporation
Sektor
Branche
Telefon
800-208-3343
Adresse
303A COLLEGE ROAD EAST, PRINCETON
Vergleichen Sie PDSB mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PDSB
Pds Biotechnology Corporation
|
1.16 | 56.22M | 0 | -40.56M | -35.28M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2022-11-01 | Eingeleitet | B. Riley Securities | Buy |
| 2021-06-28 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-10 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-05-27 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-03-09 | Eingeleitet | Noble Capital Markets | Outperform |
| 2019-10-24 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Pds Biotechnology Corporation Aktie (PDSB) Neueste Nachrichten
PDS Biotechnology Q2 2025 Earnings Call Transcript - MarketBeat
Using Python tools to backtest PDS Biotechnology Corporation strategies - Newser
Blair William & Co. IL Acquires 99,700 Shares of PDS Biotechnology Corporation (NASDAQ:PDSB) - Defense World
Earnings call transcript: PDS Biotech Q2 2025 reports narrower EPS loss, stock rises - Investing.com Australia
Short interest data insights for PDS Biotechnology Corporation2025 Earnings Impact & Real-Time Volume Surge Alerts - Newser
Market reaction to PDS Biotechnology Corporation’s recent news2025 Growth vs Value & Free Risk Controlled Daily Trade Plans - Newser
PDS Biotechnology: Q2 Earnings Snapshot - San Antonio Express-News
PDS Biotechnology Corporation: Analyzing PDSB Stock Trends - investchronicle.com
PDSB Loss Improves as Costs Drop - The Motley Fool
How to build a dashboard for PDS Biotechnology Corporation stockLong Setup & Risk Adjusted Swing Trade Ideas - Newser
Evaluating PDS Biotechnology Corporation with trendline analysis [July 2025 Sentiment]Free Daily Entry Point Trade Alerts - Newser
Should you hold or exit PDS Biotechnology Corporation now [Weekly Investment Recap]Low Risk High Reward Trade Ideas - Newser
Statistical indicators supporting PDS Biotechnology Corporation’s strength [2025 Growth vs Value]Daily Technical Stock Forecast Reports - Newser
PDS Biotechnology Corporation Forms Bullish Flag — Upside AheadEntry Zone Strategy for Consistent Profit Shared - 선데이타임즈
Smart tools for monitoring PDS Biotechnology Corporation’s price actionSmart Money Strategy for Growth Stocks - Newser
What institutional flow reveals about PDS Biotechnology CorporationFree Early Entry Tips With Low Risk Zone - Newser
Why PDS Biotechnology Corporation stock attracts strong analyst attentionFree Low Risk Swing Trade Opportunity List - Newser
What the charts say about PDS Biotechnology Corporation todayOversold Stock Bounce Playbook Generator - Newser
PDS Biotechnology Corp expected to post a loss of 23 cents a shareEarnings Preview - TradingView
PDS Biotechnology (PDSB) Projected to Post Earnings on Wednesday - Defense World
New Product Launches: Will They Boost PDS Biotechnology Corporation Stock in 2025Free Swing Trading Plan With Smart Signals - Newser
What earnings revisions data tells us about PDS Biotechnology CorporationSwing Watchlist With Tight Stop Placement - Newser
Evaluating PDS Biotechnology Corporation with trendline analysisAI Pattern Recognition and Trade Prediction - Newser
What makes PDS Biotechnology Corporation stock price move sharplyTechnical Reversal Pattern Summary and Tracker - Newser
Detecting price anomalies in PDS Biotechnology Corporation with AIScalable Strategy with Chart Confirmation - Newser
Risk adjusted return profile for PDS Biotechnology Corporation analyzedConservative Investment Setup and Risk Analysis - Newser
What Fibonacci levels say about PDS Biotechnology Corporation reboundFree Breakout Confirmation With Entry Tracker - Newser
Real time social sentiment graph for PDS Biotechnology CorporationEntry Zone Watchlist With Momentum Focus - Newser
Pds Biotechnology Corporation shares rise 1.80% after-hours following Singapore Exchange's strong financial performance. - AInvest
PDS Biotech Announces Q2 2025 Earnings Call and Webcast - AInvest
Can trapped investors hope for a rebound in PDS Biotechnology CorporationEntry Confirmation Based on Volatility Analysis - Newser
PDS Biotech Announces Conference Call and Webcast for Second Quarter 2025 Financial Results - GlobeNewswire
PDS Biotech Announces Q2 2025 Financial Results Call and Webcast - AInvest
What momentum shifts mean for PDS Biotechnology CorporationFree Conservative Long Term Growth Plans - Newser
Is PDS Biotechnology Corporation reversing from oversold territoryFree Daily Chart Pattern Stock Forecast - Newser
When is PDS Biotechnology Corporation stock expected to show significant growthPhenomenal trading returns - Jammu Links News
Should I hold or sell PDS Biotechnology Corporation stock in 2025Turn market volatility into profit opportunities - Jammu Links News
Finanzdaten der Pds Biotechnology Corporation-Aktie (PDSB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):